SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- pain
An SI Board Since December 2001
Posts SubjectMarks Bans
101 19 0
Emcee:  scaram(o)uche Type:  Moderated
Indication-specfic file folder for pain-related stuff

Please avoid chat where possible, as the posts are meant primarily as a research resource. Thanks!

Other "indication" threads.......

Subject 50997

Subject 50912

Subject 51153

Subject 51391

Subject 51033

Subject 50870

Subject 50762

Subject 50830

Subject 52061

Subject 51728

Subject 51221
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
101Basel, November 29, 2017 - Novartis today announced that the New England Journalnigel bates-1/23/2018
100Br J Pharmacol. 2014 Dec;171(23):5407-16. doi: 10.1111/bph.12851. Analgesic tolscaram(o)uche-12/16/2014
99Pharmacology. 2013 Sep 4;92(3-4):150-157. [Epub ahead of print] Pharmacology ofscaram(o)uche-9/17/2013
98J Neurosci. 2013 Sep 11;33(37):14869-77. doi: 10.1523/JNEUROSCI.0943-13.2013. Escaram(o)uche-9/17/2013
97Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritiscaram(o)uche-2/28/2013
96 To: FUBHO who wrote (20215) 10/4/2012 12:03:08 PM From: FUBHO of 20875 SCIENTIrusset-10/4/2012
95 Resolving Chronic Pain The body’s own mechanism for dispersing the inflammtnsaf-1/19/2012
94A little birdie says to agree with you. Well, make that a big, big birdie. So,scaram(o)uche-12/9/2010
93Interesting, but can't see a path to a viable target here, at least not yet.tuck-12/9/2010
92EMBO J. 2010 Dec 7. [Epub ahead of print] TRPV1-lineage neurons are required foscaram(o)uche-12/9/2010
91"Commercial Features of Placebo and Therapeutic Efficacy" High pricedtuck-10/3/2010
90FDA questions wider approval of Lilly's Cymbalta FDA questions whether Lillsim1-8/17/2010
89<b>FDA panel recommends smaller doses of painkillers</b> news.yahooidos17/1/2009
88Hey, thanks for the tidbits. Yeah, but it's also not like it was a deal sigscaram(o)uche-6/26/2009
87Given it was an early stage partnership, I think you can expect the terms to be kenhott-6/26/2009
86Anybody know the potential royalty to ICGN from Pfizer? Not implying that any &scaram(o)uche-6/25/2009
85Firewalker’s Faulty Gene May Shake Up Market for Painkillers By Dermot Doherty kenhott-6/25/2009
84FDA to require abuse plans from pain drug developers: >>UPDATE:King Pharmtuck-2/9/2009
83Curr Drug Deliv. 2008 Oct;5(4):243-7. Pro-drugs for indirect cannabinoids as thscaram(o)uche-10/20/2008
82<b>Cell protein suppresses pain 8 times more effectively than morphine<idos-10/9/2008
81Pain. 2008 Aug 22. [Epub ahead of print] Profound reduction of somatic and viscscaram(o)uche-9/6/2008
80J Pharmacol Exp Ther. 2008 Jul 29. Selective Activation of Cannabinoid CB2 Recescaram(o)uche-8/1/2008
79J Neurosci. 2008 Jun 11;28(24):6231-8. TRPV2 is activated by cannabidiol and mescaram(o)uche-7/13/2008
78Alpharma Submits NDA for Embeda: siliconinvestor.comDewDiligence_on_SI-2/28/2008
77Napo's stock price pattern sure looks familiar to this former stockholder ofJMarcus-11/29/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):